Stockholders Equity (Details) - Schedule of Outstanding and Exercisable Warrants - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule of Outstanding and Exercisable Warrants [Line Items] | ||
| Numbers of Outstanding, Beginning Balance | 10,074,195 | 10,345,784 |
| Weighted Average Exercise Price, Beginning Balance | $ 4.91 | $ 4.9 |
| Weighted Average Life (Years), Beginning Balance | 4 years | 5 years |
| Numbers of Warrants Outstanding, Warrants Issued | ||
| Weighted Average Exercise Price, Warrants Issued | ||
| Numbers of Warrants Outstanding, Warrants Exercised | (271,589) | |
| Weighted Average Exercise Price, Warrants Exercised | $ 4.81 | |
| Numbers of Outstanding, Ending Balance | 10,074,195 | 10,074,195 |
| Weighted Average Exercise Price, Ending Balance | $ 4.91 | $ 4.91 |
| Weighted Average Life (Years), Ending Balance | 4 years | 5 years |
| X | ||||||||||
- Definition Represents share based compensation arrangement by share based payment award equity instruments other than options exercised in period. No definition available.
|
| X | ||||||||||
- Definition Represents share based compensation arrangement by share based payment award equity instruments other than options exercised period weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|